Caxton Associates (New York)’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-4,240
Closed -$317K – 456
2023
Q4
$317K Buy
+4,240
New +$303K 0.02% 391
2023
Q3
– Sell
-5,325
Closed -$581K – 396
2023
Q2
$581K Buy
5,325
+1,070
+25% +$101K 0.09% 239
2023
Q1
$353K Buy
+4,255
New +$401K 0.05% 326
2021
Q4
– Sell
-9,671
Closed -$1.11M – 548
2021
Q3
$1.11M Buy
9,671
+1,019
+12% +$108K 0.12% 87
2021
Q2
$839K Buy
8,652
+5,109
+144% +$443K 0.09% 89
2021
Q1
$261K Buy
+3,543
New +$263K 0.02% 315

Other funds holding AMN

Caxton Associates (New York)'s AMN Position: Q1 2024 in Review

Caxton Associates (New York) sold out of AMN Healthcare (AMN) in Q1 2024, closing a stake of 4,240 shares — an estimated $317K sold.

Caxton Associates (New York) first reported a position in AMN in Q1 2021 and held it in 6 quarters. The position peaked at $1.11M in Q3 2021. 347 funds tracked by Wall St. Rank hold AMN as of Q1 2024.

  • Caxton Associates (New York) reported no remaining AMN Healthcare position as of Q1 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 4,240 AMN Healthcare shares in Q1 2024, an estimated $317K.
  • Caxton Associates (New York) first reported a position in AMN Healthcare in Q1 2021 and held it in 6 quarters.
  • Caxton Associates (New York)'s AMN Healthcare position peaked at $1.11M in Q3 2021.
  • 347 funds tracked by Wall St. Rank held AMN Healthcare as of Q1 2024.

Based on Caxton Associates (New York)'s 13F filing for Q1 2024, filed 15 May 2024.